Skip to main content

Table 3 Inpatient data and early complications

From: Pelvic exenteration in gynecologic cancer: complications and oncological outcome

Hospitalisation stay (days) [Mean ± SD (range)]

22.9 ± 15.9 (7–72)

ICU stay [n (%)]

2.2 ± 1.5 (1–5)

Re- surgery [n (%)]

4 (17)

TPN [n (%)]

10 (43)

Patients with transfusion [n (%)]

11 (48)

Transfusion (Units) [Mean ± SD (range)]

1.96 ± 2.7 (1–10)

Circulatory event [n (%)]

 Thromboembolism

0 (0)

 Cardiovascular event

0 (0)

Urinary [n (%)]

 No

19 (83)

 Ureter leakage

2 (9)

 Urostomy complication

1 (4)

 Renal failure

3 (13)

Gastrointestinal [n (%)]

 Paralytic ileus

6 (26)

 Leakage

0 (0)

Wound [n (%)]

 No

15 (65)

 Dehiscence

7 (30)

 Infection

5 (22)

 Haematoma

1 (4)

 Flap necrosis

1 (4)

 Lymphorrea

1 (4)

Infectious [n (%)]

 No

17 (74)

 Abscess

2 (9)

 Fever and bacteremia

3 (13)

 Sepsis

1 (4)

Respiratory [n (%)]

 Infectious

0 (0)

 Respiratory insufficiency

1 (4)

Others [n (%)]

 Motor dysfunction

1 (4)

Clavien Dindo [Mean ± SD (range)]

Grade II

1.8 ± 1.6 (0–5)

Grade III

0.3 ± 0.5 (0–2)

Grade IV

0.1 ± 0.53 (0–1)

Grade V

0 ±  (0–0)

Patients with complication [n (%)]

5 (22)

Grade II

15 (65)

Grade III

5 (22)

Grade IV

2 (9)

Grade V

0 (0)

  1. ICU Intensive Care Unit, TPN total parenteral nutrition